Crossmark

Design of more potent quinazoline derivatives as EGFRWT inhibitors for the treatment of NSCLC: a computational approach

Published Online: 2021-07-12

Published Print: 2021-12

Authors

Ibrahim, Muhammad Tukur

Uzairu, Adamu

Uba, Sani

Shallangwa, Gideon Adamu
License Information

Text and Data Mining valid from 2021-07-12

Version of Record valid from 2021-07-12
More Information

Article History

Received: 31 March 2021

Accepted: 9 June 2021

First Online: 12 July 2021

Declarations

:

: Not applicable

: Not applicable

: The authors declare that they have no competing interests.

Document is current